Prothena | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Exelixis USD 282K 4K 2025-01
Incyte USD 193K 1000 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
MacroGenics USD 628K 1000 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Prothena USD 538K 0 2024-12
Regeneron Pharmaceuticals USD 102K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Prothena Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.